Kuan C. Lei
Heidelberg, BW 69129, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Pharmacologic reversion of Merkel cell carcinoma via CBP/p300 inhibition.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 24, 2025
Tertiary lymphoid structures in Merkel cell carcinoma facilitate naïve and central memory T-cell infiltration linked to immunotherapy response.
Journal: Journal for immunotherapy of cancer
Published: August 24, 2025
High-resolution spatial transcriptomics uncover epidermal-dermal divergences in Merkel cell carcinoma: spatial context reshapes the gene expression landscape.
Journal: Oncogene
Published: February 26, 2025
Is MCPyV-Driven DNA Damage Response the Achilles' Heel of Merkel Cell Carcinoma?
Journal: The Journal of investigative dermatology
Published: May 10, 2024
Merkel cell polyomavirus pan-T antigen knockdown reduces cancer cell stemness and promotes neural differentiation independent of RB1.
Journal: Journal of medical virology
Published: January 29, 2024
Analyses of combined Merkel cell carcinomas with neuroblastic components suggests that loss of T antigen expression in Merkel cell carcinoma may result in cell cycle arrest and neuroblastic transdifferentiation.
Journal: The Journal of pathology
Published: January 02, 2024
The HDAC inhibitor domatinostat induces type I interferon α in Merkel cell carcinoma by HES1 repression.
Journal: Journal of cancer research and clinical oncology
Published: January 19, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026